Reuters logo
BRIEF-Trillium Therapeutics says TTI-621 program momentum continues in 2017
March 10, 2017 / 12:04 PM / 6 months ago

BRIEF-Trillium Therapeutics says TTI-621 program momentum continues in 2017

March 10 (Reuters) - Trillium Therapeutics Inc

* Trillium reports annual 2016 financial and operating results

* Trillium therapeutics inc - “tti-621 program momentum continues in 2017” Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below